Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

2017759 citationsJournal Articlebronze Open Access

Authors

R. Coleman Lindsley

Wael Saber · Medical College of Wisconsin

Brenton G. Mar · Dana-Farber Cancer Institute

Robert Redd · Dana-Farber Cancer Institute

Tao Wang · Medical College of Wisconsin

Michael Haagenson · National Marrow Donor Program

Peter Grauman · Brigham and Women's Hospital

Abstract

Genetic profiling revealed that molecular subgroups of patients undergoing allogeneic hematopoietic stem-cell transplantation for MDS may inform prognostic stratification and the selection of conditioning regimen. (Funded by the Edward P. Evans Foundation and others.).

Topics & Keywords

Acute Myeloid Leukemia Research Blood disorders and treatments Acute Lymphoblastic Leukemia research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 376, Issue 6, pp. 536-547

DOI: 10.1056/nejmoa1611604

Field-Weighted Citation Impact: 54.67